REGENERON PHARMACEUTICALS, INC.
REGN · XNASCIK 872589fmd_0706GFJPK8BYWG25ZEPRBSGD97Industri Pengolahan · Sediaan FarmasiTemplat: Standar
Cakupan: 01 Jan 2008 hingga 30 Sep 2026, 71 periode
| Pos laporan | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total pendapatan | 4.860 | 5.872 | 5.146 | 6.558 | 8.497 | 16.072 | 12.173 | 13.117 | 14.202 | 14.343 |
| Beban pokok pendapatan | 195 | 203 | 238 | 403 | – | – | – | – | – | – |
| Laba kotor | 4.666 | 5.670 | 4.908 | 6.155 | – | – | – | – | – | – |
| Keuntungan (kerugian) investasi yang direalisasi | – | – | – | – | – | – | – | – | – | – |
| Penelitian dan pengembangan | 2.052 | 2.075 | 1.469 | 2.450 | 2.647 | 2.860 | 3.593 | 4.439 | 5.132 | 5.850 |
| Beban penjualan, umum dan administrasi | 1.178 | 1.320 | 1.127 | 1.342 | 1.346 | 1.825 | 2.116 | 2.631 | 2.954 | 2.700 |
| Laba operasi | 1.331 | 2.080 | 2.534 | 2.210 | 3.577 | 8.947 | 4.739 | 4.047 | 3.991 | 3.578 |
| Beban bunga | 7 | 25 | 28 | 30 | 57 | 57 | 59 | 73 | 55 | 44 |
| Pendapatan (beban) nonoperasi lainnya | (1) | (1) | 19 | 219 | 234 | 379 | 120 | 152 | 789 | 1.653 |
| Laba sebelum pajak | 1.330 | 2.079 | 2.554 | 2.429 | 3.810 | 9.326 | 4.859 | 4.199 | 4.780 | 5.231 |
| Beban pajak penghasilan | 434 | 880 | 109 | 313 | 297 | 1.251 | 520 | 246 | 367 | 726 |
| Laba bersih dari operasi yang dilanjutkan | 896 | 1.199 | 2.444 | 2.116 | 3.513 | 8.075 | 4.338 | 3.954 | 4.413 | 4.505 |
| Laba bersih | 896 | 1.199 | 2.444 | 2.116 | 3.513 | 8.075 | 4.338 | 3.954 | 4.413 | 4.505 |
| Laba bersih yang diatribusikan kepada pemegang saham biasa | – | – | – | – | – | – | – | – | – | – |